Terms: = Ovarian cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
17 results:
1. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
2. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
3. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
4. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of Twenty Genes in prognosis of Patients with ovarian cancer Using Four Different Clustering Methods.
Pourahmad S; Foroozani S; Nourelahi M; Hosseini A; Razmkhah M
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1781-1787. PubMed ID: 34181334
[TBL] [Abstract] [Full Text] [Related]
6. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract] [Full Text] [Related]
7. Lin28A Regulates Stem-like Properties of ovarian cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression.
Zhong Y; Cao L; Ma H; Wang Q; Wei P; Yang J; Mo Y; Cao L; Shuai C; Peng S
Int J Biol Sci; 2020; 16(11):1941-1953. PubMed ID: 32398961
[TBL] [Abstract] [Full Text] [Related]
8. [Pathologic features on gonadal changes of sexual developmental disorders in children].
Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
[No Abstract] [Full Text] [Related]
9. [Expressions of oct4, Notch1 and DLL4 and their clinical implications in epithelial ovarian cancer].
Yu L; Jiao YJ; Zhou L; Song WQ; Wu SW; Wang DN
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):444-450. PubMed ID: 28446394
[TBL] [Abstract] [Full Text] [Related]
10. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
Liu J; Wang L; Wang Y; Zhang W; Cao Y
PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
[TBL] [Abstract] [Full Text] [Related]
11. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.
Liang L; Zhang Y; Malpica A; Ramalingam P; Euscher ED; Fuller GN; Liu J
Mod Pathol; 2015 Dec; 28(12):1613-20. PubMed ID: 26564007
[TBL] [Abstract] [Full Text] [Related]
12. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating oct4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract] [Full Text] [Related]
13. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
Howitt BE; Brooks JD; Jones S; Higgins JP
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
[TBL] [Abstract] [Full Text] [Related]
14. Lin28 regulates BMP4 and functions with oct4 to affect ovarian tumor microenvironment.
Ma W; Ma J; Xu J; Qiao C; Branscum A; Cardenas A; Baron AT; Schwartz P; Maihle NJ; Huang Y
Cell Cycle; 2013 Jan; 12(1):88-97. PubMed ID: 23255092
[TBL] [Abstract] [Full Text] [Related]
15. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract] [Full Text] [Related]
16. oct4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract] [Full Text] [Related]
17. oct4: a novel biomarker for dysgerminoma of the ovary.
Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
[TBL] [Abstract] [Full Text] [Related]
